Ocular gene therapy: The basic science and current state of research

Australian and New Zealand Journal of Ophthalmology

Volumn 25, Issue 2, 1997, Pages 97-104

  Da Cruz, Lyndon ^a,b   Rakoczy, P ^a   Constable, I ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b LIONS EYE INSTITUTE   (Australia)

Author keywords

Adenovirus; Antisense; Gene insertion; Gene therapy; Ribozyme; Viral gene transfer

Indexed keywords

ADENOVIRUS; ANIMAL TISSUE; BIRTH DEFECT; ENZYME DEFICIENCY; EYE MALFORMATION; GENE INSERTION; GENE TRANSFER; HUMAN; HUMAN TISSUE; MEDICAL RESEARCH; MOUSE; NONHUMAN; RETINA DEGENERATION; RETINITIS PIGMENTOSA; REVIEW; VIRUS GENE;

EID: 0030813313     PISSN: 08149763     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1442-9071.1997.tb01289.x     Document Type: Review

References (45)

1. Lodish H, Baltimore D, Berk A, Zipursky SL, Matsudaira P, Darnell. Molecular Cell Biology, 3rd edn. New York: Scientific American Books, 1995.
2. Newell FW. Ophthalmology Principles and Concepts, 7th edn. St Louis: Mosby Year Book, 1992.
3. Stone EM, Nichols BE, Streb LM, Kimura AE, Sheffield VC. Genetic linkage of vitelliform macular degeneration (Best's disease) to chromosome 11q13. Nature Genet. 1992; 1: 246-50.
4. Zhang K, Nguyen TE, Crandall A, Donoso LA. Genetic and molecular studies of macular dystrophies: Recent developments. Surv. Ophthalmol. 1995; 40: 51-61.
5. Lem J, Flannery GJ, Li T, Applebury ML, Farber D, Simon M. Retinal degeneration is rescued in transgenic rd mice by expression of the cGMP phosphodiesterase β sub-unit. Proc. Natl Acad. Sci. USA 1992; 89: 4422-6.
6. Travis GH, Groshan KR, Lloyd M, Bok D. Complete rescue of photoreceptor dysplasia and degeneration in transgenic retinal degeneration slow (rds) mice. Neuron 1992; 9: 113-19.
7. Old RW, Primrose SB. Principles of Gene Manipulation, 5th edn. Blackwell Science, 1994.
8. Zimmerman U, Vienken J. Electric field induced cell to cell fusion. J. Membr. Biol. 1983; 67: 1-10.
9. Olsson JE, Gordon JW, Pawlyk BS et al. Transgenic mice with a rhodopsin mutation (Pro23His): A mouse model of autosomal dominant retinitis pigmentosa. Neuron 1992; 9: 815-30.
10. Lyerly HK, DiMaio JM. Gene delivery systems in surgery. Arch. Surg. 1993; 128: 1197-1206.
11. Pepose JS, Leib DA. Herpes simplex viral vectors for therapeutic gene delivery to ocular tissues: Recent breakthroughs in the molecular genetics of ocular diseases. Invest. Ophthalmol. Vis. Sci. 1994; 35: 2662-6,
12. Kasahara N, Dozy AM, Kan YW. Tissue-specific targeting of retroviral vectors through ligand-receptor interactions. Science 1994; 266: 1373-6.
13. Muzyczka N. Adeno-associated virus (AAV) vectors: Will they work? J. Clin. Invest. 1994; 94: 1351.
14. Ali M, Lemoine NR, Ring CJA. The use of DNA viruses for gene therapy. Gene Ther. 1994; 1: 367-84.
15. Mashhour B, Couton D, Perricaudet M, Briand P. In vivo adenovirus-mediated gene transfer into ocular tissues. Gene Ther. 1994; 1: 122-6.
16. Li T, Adamain M, Roof DJ et al. In vivo transfer of a reporter gene to the retina mediated by an adenoviral vector. Invest. Ophthalmol. Vis. Sci. 1994; 35: 2543-9.
17. Bennet J, Wilson J, Sun D, Forbes B, Maguire A. Adenovirus vector-mediated in vivo gene transfer into adult murine retina. Invest. Ophthalmol. Vis. Sci. 1994; 35: 2535-42.
18. Kozarsky KF, Wilson JM. Gene therapy: adenovirus vectors. Curr. Opin. Genet. Dev. 1993; 3: 499-503.
19. Stein CA, Cheng YC. Antisense oligonucleotides as therapeutic agents: Is the bullet really magical? Science 1993; 261: 1004-12.
20. Rakoczy P, Mann K, Cavaney DM, Robertson T, Papadimitreou J, Constable IJ. Detection and possible functions of a cysteine protease involved in digestion of rod outer segments by retinal pigment epithelial cells: Antisense to the eye. Invest. Ophthalmol Vis. Sci. 1994; 35: 4100-8.
21. Scanlon KJ, Jiao L, Funato T et al. Ribozyme-mediated cleavage of c-fos mRNA reduces gene expression of DNA synthesis enzymes and metallothionein. Proc. Natl Acad. Sci. USA 1991; 88: 10591-5.
22. Haseloff J, Gerlash WL. Simple RNA enzymes with new and highly specific endoribonuclease activities. Nature 1988; 334: 585-91.
23. Murarella MA. Gene mapping of ocular diseases. Surv. Ophthalmol. 1992; 36: 285-312.
24. Della NG. The revolution in molecular genetics and its impact on ophthalmology. Aust. N.Z. J. Ophthalmol. 1996; 24: 85-97.
25. McLaughlin ME, Sandberg MA, Berson EL, Dryja TP. Recessive mutations in the gene encoding the β-subunit of rod phosphodiesterase in patients with retinitis pigmentosa. Nature Genet. 1993; 4: 130-3.
26. Nichols BE, Sheffield VC, Vandenburgh K, Drack AV, Kimura AE, Stone EM. Butterfly-shaped pigment dystrophy of the fovea caused by a point mutation in codon 167 of the RDS gene. Nature Genet. 1993; 3: 202-7.
27. McLaughlin ME, Ehrhart TL, Berson EL, Dryja TP, Mutation spectrum of the gene encoding the b-subunit of rod phosphodiesterase among patients with autosomal recessive retinitis pigmentosa. Proc. Natl Acad. Sci. USA 1995; 92: 3249-53.
28. Travis GH, Brennan MB, Danielson PE, Kozak CA, Sutcliffe JG. Identification of a photoreceptor-specific mRNA encoded by the gene responsible for retinal degeneration slow (rds). Nature 1989; 338: 70-3.
29. Stramm LE, Wolfe JH, Schuchman EH, Haskins ME, Patterson DE, Aguirre GD. β-glucuronidase mediated pathway essential for retinal pigment epithelial degradation of glycosaminoglycans: Disease expression and in vitro disease correction using retroviral mediated cDNA transfer. Exp. Eye Res. 1990; 50: 521-32.
30. Streilein JW. Immune regulation and the eye: A dangerous compromise. FASEB J. 1987; 1: 199-208.
31. Mulligan RC. The basic science of gene therapy. Science 1993; 260; 926-32.
32. Lacorazza HD, Jendoubi M. Correction of ornithine-δ-amino-transferase deficiency in a Chinese hamster ovary cell line mediated by retrovirus gene transfer. Gene Ther. 1995; 2: 22-8.
33. Abraham NG, DaSilva J-L, Lavrovsky Y et al. Adenovirus-mediated heme oxygenase gene transfer into rabbit ocular tissues. Invest. Ophthalmol. Vis. Sci. 1995; 36: 2202-10.
34. Budenz DL, Bennett J, Alonso L, Maguire A. In vivo gene transfer into murine corneal endothelial and trabecular meshwork cells. Invest. Ophthalmol. Vis. Sci. 1995; 36: 2211-15.
35. Borras T, Zigler JS. Adenovirus mediated gene transfer into whole monkey lens in organ culture. Invest. Ophthalmol. Vis. Sci. 1995; 36: 3882.
36. Jommary C, Vincent KA, Muzyczka N et al. Adeno-associated virus vector-mediated gene transfer to retinal cells in vitro and in vivo. Invest. Ophthalmol Vis. Sci. 1995; 36: 3569.
37. Tanabe T, Gouras P, Bennett J, Kjeldbye H. Gene therapy slows the retinal degeneration in rd mice. Invest Ophthalmol. Vis. Sci. 1985; 36: 3886.
38. Bennett J, Maguire AM. Delayed retinal degeneration after adenovirus-mediated gene therapy. Invest. Ophthalmol. Vis. Sci. 1995; 36: 3920.
39. Wong F. How shall research in the treatment of retinitis pigmentosa proceed? Arch. Ophthalmol. 1993; 111: 754-6.
40. Pedroza L, Thompson HW, Pearce AR, Nguyen D, Beuerman RW. In vivo gene transfer and expression in the lacrimal gland. Invest. Ophthalmol. Vis. Sci. 1995; 36: 4586.
41. Maxwell IH, Spitzer AL, Long CJ, Maxwell F. Autonomous parvovirus transduction of a gene under control of tissue-specific or inducible promoters. Gene Ther. 1996, 3: 28-36.
42. Rakoczy P, Lai MC, Vijayasekaran S et al. Initiation of impaired outersegment degradation in vivo using an antisense oligonucleotide. Curr. Eye Res. 1996; 15: 119-23.
43. Anderson WF. Hum. Gene therapy. Science 1993; 260: 914-15.
44. Deonarain MP, Spooner RA, Epenetos AA. Genetic delivery of enzymes for cancer therapy. Gene Ther. 1995; 2: 235-44.
45. Zack DJ. Ocular gene therapy: From fantasy to foreseeable reality. Arch. Ophthalmol. 1993; 111: 1477-8.